Testing inhaled treatment for allergic asthma responses

This study is testing a new inhaled medication called ARO-RAGE to see if it can help reduce the delayed airway problems that occur after someone with mild allergic asthma is exposed to their allergen. Researchers want to understand whether this treatment can improve how well the small airways in your lungs work after an allergic reaction. Half of participants will receive the medication, and half will receive a placebo (salt water) for comparison.

People with allergic asthma often experience a delayed reaction—hours after exposure to an allergen—where their airways become inflamed and narrow. Current treatments don't always control this delayed response well, so researchers are testing whether this new medication could provide better relief.